Dextromine (Chlorphenamine,Dextromethorphan)

Quick links

Choose a section

Quick links to important sections

Advertisements

Dextromine (Chlorphenamine,Dextromethorphan)

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Dextromine (Chlorphenamine,Dextromethorphan)

What Type of Medicine is Dextromine? (Chlorphenamine, Dextromethorphan)

Dextromine (Chlorphenamine, Dextromethorphan) is a synthetic, fixed-dose combination (FDC) medicine taken orally that contains two distinct active ingredients to provide relief for symptoms of the common cold and allergies. This preparation is classified pharmacologically as a combination of a first-generation Antihistamine (Chlorphenamine) and a non-opioid Cough Suppressant (Dextromethorphan). This FDC approach is designed for managing concurrent cold symptoms.

Chlorphenamine is identified as an Alkylamine derivative, while Dextromethorphan is a synthetic Morphinan derivative. This FDC design specifically addresses scenarios where upper respiratory symptoms involve both allergic rhinitis elements and a persistent cough, utilizing a therapeutic strategy that combines agents from two different pharmacological classes.


Composition and Available Forms of Dextromine

The active components in this combination are Chlorphenamine (often formulated as the Maleate salt) and Dextromethorphan (commonly used as the Hydrobromide salt). These compounds are available in various oral dosage forms, including tablets, syrups, and oral solutions.

Chlorphenamine serves as the antihistamine component and Dextromethorphan as the antitussive within the combination. The availability of both liquid forms and solid forms allows for different methods of administration, which may be selected based on the user group or preference.


General Purpose: What Does the Chlorphenamine-Dextromethorphan Combination Relieve?

The general purpose of the Dextromine combination is to provide symptomatic relief for the concurrent symptoms of upper respiratory irritation, particularly those associated with the common cold and seasonal allergies. The Chlorphenamine component works through histamine blockade to dry up secretions and lessen allergic responses. The Dextromethorphan component contributes to relief by acting on the cough center in the brain, thereby suppressing the non-productive cough reflex. This dual action is designed to alleviate general irritation, such as sneezing, a runny nose, and an irritating cough.

Regulatory References

  1. MedlinePlus: Chlorpheniramine and Dextromethorphan
  2. DailyMed/FDA Drug Label: Chlorpheniramine/Dextromethorphan
Advertisements

What side effects are possible with Dextromine (Chlorphenamine,Dextromethorphan)?

The official safety profile of Dextromine, a combination of an antihistamine (Chlorphenamine) and a cough suppressant (Dextromethorphan), outlines adverse reactions based on government regulatory documentation. The most characteristic effects are related to the central nervous system (CNS) and anticholinergic activity, which are formally classified by frequency.

Officially Classified Adverse Reactions

The most frequent effects are primarily linked to the antihistamine component:

  • Very Common (ge 1/10): Sedation and somnolence (drowsiness).
  • Common (ge 1/100 to <1/10): Dizziness, headache, disturbance in attention, abnormal coordination, blurred vision, dry mouth, nausea, and fatigue.

Reactions are documented across multiple System-Organ Classes, including Nervous System, Gastrointestinal, Cardiac/Vascular, and Immunologic. Other documented effects with frequency listed as Not Known include confusion, restlessness, palpitations, arrhythmias, vomiting, hepatitis, and urinary retention.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions, though typically rare, that are formally listed include blood dyscrasias (e.g., haemolytic anaemia), anaphylactic reactions, and convulsions (seizures).

Population-Specific Safety: Older adults are noted to be more susceptible to anticholinergic effects like confusion and difficulty urinating, while children may sometimes experience paradoxical excitation instead of sedation.

Safety Restrictions: The medicine is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs), or within two weeks of stopping an MAOI, due to the risk of severe reaction. Concurrent use with alcohol, sedatives, or tranquilizers is officially noted to increase the sedative effects. Caution is also advised in individuals with pre-existing conditions such as narrow-angle glaucoma and severe cardiovascular or hepatic impairment.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Dextromine, a combination of Chlorphenamine and Dextromethorphan, involves documented risks to the central nervous system (CNS) and cardiopulmonary systems. Officially documented overdose manifestations include severe drowsiness, excitation, confusion, hallucinations, and signs of anticholinergic toxicity, such as fixed, dilated pupils and hyperpyrexia (high fever).


Regulator-Documented Severe Outcomes

Severe or life-threatening outcomes described in regulatory documents include respiratory depression (shallow or stopped breathing), convulsions or seizures, coma, cardiac arrhythmias, and cardiovascular collapse. The official labeling also notes the potential risk of Serotonin Syndrome (Serotonin Toxicity) with excessive Dextromethorphan exposure.


Emergency Action Requirements

Immediate medical attention or contact with a Poison Control Center is required if an overdose is suspected. Urgent medical services should be contacted if the affected individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. Treatment is classified as symptomatic and supportive. While no specific antidote exists for Chlorphenamine, regulatory information states that Naloxone may be used to counteract Dextromethorphan-induced respiratory depression. Hospital monitoring, including ECG and vital signs checks, is a mandated measure.


Population Considerations

Regulatory documents note that both children and the elderly are at an increased risk of severe effects; children may exhibit paradoxical excitation, while older patients are more likely to experience confusion and toxicity.

Advertisements

Therapeutic Uses of Dextromine (Chlorphenamine,Dextromethorphan)

What Dextromine (Chlorphenamine,Dextromethorphan) Treats: Main Uses and Benefits

Dextromine is intended for providing temporary, symptomatic assistance during episodes of cold and allergy. This combination is generally used in scenarios where short-term management of respiratory discomfort is appropriate.


Therapeutic Applications

The medication is commonly used for conditions presenting with acute episodes of upper respiratory irritation, including hay fever and the common cold. It helps manage symptom clusters that may appear suddenly, such as a runny nose, sneezing, watery eyes, itchiness of the nose or throat, and an associated dry, non-productive cough. This provides support that contributes to easing the overall symptom load when multiple symptoms occur together.

“This formulation helps address symptoms that interfere with daily comfort, particularly the clustering of cough and allergic manifestations.”

Quick Fact: Focus on Dual Symptom Support

Quick Fact: Focus on Dual Symptom Support for Combined Cough and Allergic Irritation is commonly sought with this product. This supportive management is applied during phases when symptoms become more noticeable, may assist with maintaining functional stability, and supports day-to-day comfort.

Regulatory References

  1. National Library of Medicine (NIH)
Advertisements

Eligibility and Restrictions for Use

Population Eligibility and Restrictions

Absolute Contraindications

Use of Dextromine is strictly contraindicated for patients currently taking or who have stopped Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days. The medicine is also prohibited for individuals diagnosed with narrow-angle glaucoma, urinary retention, severe hypertension, or severe coronary artery disease, as established by regulatory labeling.

Age-Based Eligibility Rules

Dextromine is contraindicated in children under 2 years of age. Furthermore, regulatory guidance often advises against the use of these ingredients in children under four or six years, depending on the jurisdiction. Older adults (60 years and older) should use with caution due to increased sensitivity, and the Chlorphenamine component is identified as potentially inappropriate for adults 65 years and older.

Conditional Use and Organ Function

Caution is required for individuals with severe hepatic impairment or severe renal impairment as stated in the label. The medicine is generally not advised for a persistent or chronic cough (such as with emphysema) or a cough producing excessive secretions. The medicine is assigned FDA Pregnancy Category C. During lactation, the manufacturer advises discontinuing either nursing or the drug itself due to potential serious effects on the infant.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Formal Contraindications and Restrictions

Co-administration of Dextromine is formally contraindicated with all Monoamine Oxidase Inhibitors (MAOIs). This restriction is based on the risk of Serotonin Syndrome and mandates a 14-day mandatory separation window between discontinuing an MAOI and starting Dextromine, or vice versa. The combination is also restricted with certain QT-prolonging drugs that are metabolized by the same enzyme system.

Documented Pharmacodynamic and Pharmacokinetic Interactions

Pharmacodynamic Interactions lead to additive effects, notably with other Central Nervous System (CNS) Depressants (including opioid analgesics and sedatives), resulting in increased drowsiness and impaired coordination. The use of Dextromine with other serotonergic agents (e.g., SSRIs, TCAs) is documented to increase the potential for Serotonin Syndrome. Due to the Chlorphenamine component, effects of anticholinergic drugs may be enhanced.

Pharmacokinetic Interactions involve the metabolism of Dextromethorphan by the CYP2D6 enzyme. Co-administration with potent CYP2D6 inhibitors (e.g., Fluoxetine, Quinidine) may officially increase the systemic plasma concentration and reduce the clearance of Dextromethorphan.

Substance and Population Considerations

The regulatory labeling advises against concurrent use with alcohol due to additive CNS depression. Grapefruit juice may also increase drug exposure. The risk of additive CNS depressant effects is noted to be increased in elderly or debilitated patients.

Advertisements

Mechanism of Action

How Dextromine (Chlorphenamine, Dextromethorphan) Works

The combination drug Dextromine exerts its pharmacodynamic effects through two distinct, non-overlapping mechanistic domains targeting the central and peripheral nervous systems.


H1 Receptor Antagonism and Histamine Modulation

This activity is mediated by Chlorphenamine, which acts as a first-generation antihistamine. It functions by competitively binding to and blocking peripheral H1 histamine receptors . This interaction suppresses the signaling cascade normally initiated by the endogenous mediator histamine. The downstream consequence is the modulation of physiological responses affecting local vascular permeability and afferent nerve activity.


N-methyl- D-aspartate (NMDA) Receptor Modulation

This domain is mediated by Dextromethorphan, which acts primarily as an NMDA receptor antagonist within the central nervous system, specifically the medullary cough center. The binding and blockade of these receptors modify the early molecular steps in the NMDA receptor-mediated signaling sequences. This functional inhibition influences processes responsible for afferent signal processing and causes an alteration in signal transduction efficiency within the medulla, thereby affecting the system-level excitability of the cough reflex arc.

Advertisements

Dosage and Administration Information

The administration of Dextromine, a fixed-dose combination, follows a standardized oral route for all dosage forms, which include tablets, oral solutions, and syrups. Usage is typically structured as an intermittent, as-needed regimen for temporary symptomatic assistance.


Standard Dosage and Frequency

For adults and children 12 years of age and older, the dose—such as one tablet containing 4 mg of Chlorphenamine and 30 mg of Dextromethorphan—is generally taken every 4 to 6 hours. The total dose administered must not exceed four doses within any 24-hour period. This limit applies across all available forms, including oral solutions, which must be measured precisely using a dedicated dosing cup or syringe provided with the product. The medicine may be taken independently of meals, as no specific food requirements are mandated for administration.


Age-Specific Administration and Course Duration

Standard protocols are established for different age groups. The regimen for adults (12 years and over) differs from that for younger children. For pediatric users aged 6 to under 12 years, the required dose is reduced, and use in children under 6 years is generally restricted. Regardless of the age group, the combination is designated solely for short-term use, and administration is not intended to exceed a maximum duration of seven days. If a dose is missed, administration should resume with the next dose when needed, ensuring the minimum 4-to-6 hour interval between doses is maintained to prevent exceeding the maximum daily intake.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Dextromine (Chlorphenamine, Dextromethorphan)

This overview summarizes the scientific evidence and research landscape for the combination of Chlorphenamine and Dextromethorphan, focusing on what studies have been conducted and what remains unclear according to authoritative regulatory and peer-reviewed sources.


Evidence for Symptomatic Relief of Common Cold Symptoms

Research primarily uses short-term Randomized Controlled Trials (RCTs) and systematic reviews exploring how symptoms change over time in adults and older children (generally ge 12 years). Studies examine patient-reported outcomes related to overall symptom load and the intensity of specific symptoms like sneezing and runny nose. Findings describe patterns observed over short treatment periods (3 to 10 days).

The research examined outcomes when the combination was compared to an inactive control substance. However, comparative evidence is lacking when assessing the specific advantage of the fixed-dose combination versus its single active ingredients. Long-term effects are not fully established due to limited follow-up durations.


Evidence for Cough and Allergic Symptoms

The Dextromethorphan component was studied for outcomes related to acute cough using short-term trials that monitored objective cough counts or patient-reported discomfort, primarily in adults. Findings were often mixed, and certainty remains low for the cough suppressant component. For allergic symptoms, evidence is derived from short-term RCTs focusing on the antihistamine component, tracking outcomes like sneezing and runny nose severity. A key limitation is that evidence supporting the allergic symptoms may be extrapolated from studies involving antihistamine-decongestant products, not this specific pairing.


Evidence in Specific Age Groups and Limitations

The most extensive research has been conducted on adults and older children. Conversely, the combination was studied for use in very young children, but efficacy has not been established in this population. Authoritative regulatory reviews report that controlled data showing a clear clinical outcome in children under six years of age are absent.

What remains unclear includes the precise benefit of the combination versus its individual components, the durability of short-term effects, and the lack of sufficient data for groups like pregnant women or those with significant comorbidities.

Key Studies & References

  1. Antihistamines and the common cold: a review and critique of the literature (Study on Antihistamines and Symptom Scores)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Dextromine (Chlorphenamine,Dextromethorphan) (FAQ)


Q: Why might Dextromine cause side effects such as dry mouth or blurred vision?

Dry mouth and blurred vision are common side effects listed in official documents for this combination medicine. These effects are linked to the Chlorphenamine component, which has known anticholinergic activity. This type of activity can affect various involuntary body functions, including the production of tears and saliva.


Q: What is the official description of serotonin syndrome risk associated with Dextromethorphan?

Regulatory warnings note that the combination of Dextromine with certain other drugs, particularly Monoamine Oxidase Inhibitors (MAOIs), carries a risk of serotonin syndrome. This is a potentially serious condition affecting the nervous system. Symptoms described in official information can range from mild (shivering and diarrhea) to more severe manifestations like high fever and muscle rigidity.


Q: Are there specific official warnings for Dextromine use in people with an enlarged prostate?

Official product warnings state that consulting a doctor is necessary before using Dextromine if a patient has certain conditions. This includes having trouble urinating due to enlargement of the prostate gland or a chronic breathing problem. This caution is noted in regulatory labels due to the drug’s potential anticholinergic effects.


Q: Does Dextromine affect the ability of the body to produce breast milk?

Official data indicates that occasional, small doses of the antihistamine component may not pose a risk; however, larger or prolonged use might decrease the milk supply in some individuals. Due to potential serious effects on the infant, official guidance advises that a person should discontinue either nursing or the drug.


Q: What is the main difference between Chlorphenamine and a second-generation antihistamine like cetirizine?

The main difference, according to regulatory overviews, relates to how the drug acts in the body. First-generation antihistamines like Chlorphenamine have an increased ability to pass the blood-brain barrier, which is why effects like drowsiness are commonly experienced. Second-generation antihistamines are generally associated with a reduced potential for this effect.


Q: What does the term anticholinergic mean in the context of Chlorphenamine?

The term anticholinergic describes a substance that blocks specific nerve impulses in the body's parasympathetic nervous system. In the context of Chlorphenamine, this blocking activity affects various involuntary functions. These effects include the modulation of secretions and functions related to the eyes, bladder control, and digestion.


Q: Is there research on how Dextromine might affect someone's ability to drive or operate machinery?

Official product labeling issues a direct caution regarding the use of Dextromine. Because marked drowsiness is a very common side effect, patients are cautioned to use care when engaging in activities such as driving a motor vehicle or operating machinery. This caution should be exercised until the individual understands how the product affects them.


Q: What is the difference between a cough suppressant (antitussive) and an expectorant?

According to definitions provided by regulatory bodies, an antitussive (cough suppressant) works to stop the cough reflex by acting on the cough center in the brain. This differs from an expectorant, which is intended to help loosen phlegm or mucus, making any coughing that occurs more productive.


Q: Does Dextromine help with nasal congestion, even though it does not contain a decongestant like phenylephrine?

The official uses listed on the drug label do not include temporary relief of nasal congestion. Regulatory information indicates that Dextromine’s intended purpose is to provide relief for specific symptoms such as cough, runny nose, and sneezing.


Q: Does Dextromine contain any ingredients that are known to help reduce a fever?

The active ingredients in this combination medicine are Chlorphenamine and Dextromethorphan. Official product labeling confirms that Dextromine does not contain a separate pain reliever or fever reducer (such as acetaminophen or ibuprofen) as an active ingredient.


Q: Can Dextromine be safely taken at the same time as a pain reliever like ibuprofen or acetaminophen?

Regulatory information does not list a specific formal interaction with non-sedating pain relievers like ibuprofen or acetaminophen. However, official warnings caution against taking Dextromine with any other product that may also cause drowsiness or sedation.


Q: What is the main risk of taking too much Dextromethorphan by combining different cold products?

The main risk of taking too much Dextromethorphan, often by combining products, is the potential for severe effects on the nervous system. According to regulatory overviews, high doses can lead to effects similar to dissociative hallucinogens and increases the potential risk of developing serotonin syndrome, which is considered life-threatening.


Q: How is this combination drug different from a product containing only a decongestant and pain reliever?

The difference lies in the pharmacological classes of the active ingredients. Dextromine is a combination of an antihistamine and a cough suppressant. This makes it distinct from products that contain a nasal decongestant and a pain reliever/fever reducer, which serve different primary functions.


Q: How does the combination drug differ from one that contains an expectorant like guaifenesin?

The difference relates to the drug's mechanism of action. The cough suppressant component of Dextromine is intended to reduce the urge to cough by acting on the brain. This function is different from that of an expectorant, which is meant to help manage and loosen phlegm.


Q: Can Dextromine cause constipation or other gastrointestinal changes?

Common gastrointestinal side effects listed in official documents include nausea and vomiting. Constipation may also occur because the antihistamine component has anticholinergic activity, which can slow down movement in the digestive system.


Q: Does Dextromine contain any sugar, sodium, or phenylalanine that people with dietary restrictions should know about?

Official labeling provides a list of inactive ingredients, which typically include components like lactose, sodium-containing components, and colorings. People with dietary restrictions or conditions like phenylketonuria must check the specific product label of their formulation, as the presence of ingredients like sugar or phenylalanine varies by manufacturer and form (e.g., tablet vs. syrup).

Advertisements

How should Dextromine (Chlorphenamine,Dextromethorphan) be stored and disposed of?

How to Store and Dispose of Dextromine (Chlorphenamine,Dextromethorphan)

Official regulatory documents define specific conditions for storing this combination medicine to maintain its stability.


Official Storage Conditions

The product must be stored at Controlled Room Temperature, typically 20°C to 25°C (68°F to 77°F). It is mandatory to keep out of reach of children. Liquid formulations must not be refrigerated and require protection from excessive heat or humidity. Liquid containers should be kept tightly closed, and solid dose forms must not be used if the blister is torn or broken.


Handling and Disposal

While universal household disposal procedures are not uniformly specified, immediate contact with a Poison Control Center is the mandatory instruction in case of accidental overdose.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dextromine (Chlorphenamine,Dextromethorphan) found in:

A-Z Index: